We only have this paper's title and publication details.
Read it at the sourceEltanexor shows potential to reduce tumorigenesis by affecting the Wnt/β-catenin signaling pathway in colorectal cancer, indicating its therapeutic relevance.
Figure S5. Eltanexor-treatment is well-tolerated in Apcmin/+ mice.
No takes yet. Share an insight, caveat, or question.
Evans et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: